Molecular targets for detection and immunotherapy in Cryptosporidium parvum

Biotechnology Advances

Volumn 25, Issue 1, 2007, Pages 13-44

  Boulter Bitzer, Jeanine I ^a   Lee, Hung ^a   Trevors, Jack T ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cryptosporidium parvum; Immunotherapy; Monoclonal antibody; Polyclonal antibody; Recombinant antibody; Vaccine

Indexed keywords

ANTIGENS; CYTOLOGY; DISEASES; IMMUNOLOGY; MOLECULAR BIOLOGY; MONOCLONAL ANTIBODIES; PROTEINS;

CRYPTOSPORIDIUM PARVUM; IMMUNOTHERAPY; POLYCLONAL ANTIBODY; RECOMBINANT ANTIBODY;

PROTOZOA;

PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ANTIBODY; DETECTION METHOD; DISEASE TREATMENT; IMMUNOCONTRACEPTION; MOLECULAR ANALYSIS; PARASITIC DISEASE; PROTOZOAN; VACCINE; VIABILITY;

ANIMAL; CLASSIFICATION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; EPIDEMIOLOGY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; METHODOLOGY; PARASITOLOGY; PATHOGENICITY; REVIEW;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; HUMANS; IMMUNOTHERAPY; SEROEPIDEMIOLOGIC STUDIES;

ANIMALIA; CRYPTOSPORIDIUM PARVUM; PROTOZOA;

EID: 33845918819     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2006.08.003     Document Type: Review

References (166)

1. Abrahamsen M.S., Templeton T.J., Enomoto S., Abrahante J.E., Zhu G., Lancto C.A., et al. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 304 (2004) 441-445
2. Anusz K.Z., Manson P.H., Riggs M.W., and Perryman L.E. Detection of Cryptosporidium parvum oocysts in bovine feces by monoclonal antibody capture enzyme-linked immunosorbent assay. J Clin Microbiol 28 (1990) 2770-2774
3. Arrowood M.J. Diagnosis. In: Fayer R. (Ed). Cryptosporidium and cryptosporidiosis (1997), CRC Press, Inc., Boca Raton 251
4. Arrowood M.J., Mead J.R., Mahrt J.L., and Sterling C.R. Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in noenatal mice. Infect Immun 57 (1989) 2283-2288
5. Arrowood M.J., Sterling C.R., and Healey M.C. Immunofluorescent microscopial visualization of trails left by gliding Cryptosporidium parvum sporozoites. J Parasitol 77 (1991) 315-317
6. Barnes D.A., Bonnin S., Huang J.X., Gousset L., Wu J., Gut J., et al. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol Biochem Parasitol 96 (1998) 93-110
7. Bjorneby J.M., Riggs M.W., and Perryman L.E. Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites. J Immunol 145 (1990) 298
8. Bonafonte M.T., Smith M.L., and Mead J.R. A 23-kDa recombinant antigen of Cryptosporidium parvum induces a cellular immune response on in vitro stimulated spleen and mesenteric lymph node cells from infected mice. Exp Parasitol 96 (2000) 32-41
9. Bonnin A., Dubremetz J.F., and Camerlynck P. Characterization of microneme antigens of Cryptosporidium parvum (Protozoa Apicomplexa). Infect Immun 59 (1991) 1703-1708
10. Bonnin A., Dubremetz J.F., and Camerlynck P. A new antigen of Cryptosporidium parvum micronemes possessing epitopes cross-reactive with macrogamete granules. Parasitol Res 79 (1993) 8-14
11. Bonnin A., Ojcius D.M., Souque P., Barnes D.A., Doyle P.S., Gut J., et al. Characterization of a monoclonal antibody reacting with antigen-4 domain of gp900 in Cryptosporidium parvum invasive stages. Parasitol Res 87 (2001) 589-592
12. Caccio S.M. Molecular epidemiology of human cryptosporidiosis. Parassitologia 47 (2005) 185-192
13. Carey C.M., Lee H., and Trevors J.T. Biology, persistence, and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst. Water Res 38 (2004) 818-862
14. Cevallos A.M., Bhat N., Verdon R., Hamer D.H., Stein B., Tzipori S., et al. Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect Immun 68 (2000) 5167-5175
15. Cevallos A.M., Zhang X., Waldor M.K., Jaison S., Zhou X., Tzipori S., et al. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun 68 (2000) 4108-4116
16. Chappel C.L., Okhuysen P.C., Sterling C.R., Wang C., Jakubowski W., and Dupont H.L. Infectibity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin. Am J Trop Med Hyg 60 (1999) 157-164
17. Chen X., and LaRusso N.F. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterology 118 (2000) 368-379
18. Chen X., Keithly J.S., Paya C.V., and Larusso N.F. Cryptosporidioisis. N Engl J Med 346 (2002) 1723-1731
19. Chen L., Williams B.R., Yang C.-Y., Cevallos A.M., Bhat N., Ward H., et al. Polyclonal Fab phage display libraries with a high percentage of diverse clones to Cryptosporidium parvum glycoproteins. Int J Parasitol 33 (2003) 281-291
20. Crabb J.H. Antibody-based immunotherapy of cryptosporidiosis. Adv Parasitol 40 (1998) 121-149
21. Current W.L. Cryptosporidium: its biology and potential for environmental transmission. CRC Crit Rev Environ Control 17 (1986) 21
22. de Geus B. The next generation of antibodies: production of recombinant antibodies or fragments derived thereof. Res Immunol 149 (1998) 587-589
23. Deng M., Templeton T.J., London N.R., Bauer C., Schroeder A.A., and Abrahamsen M.S. Cryptosporidium parvum genes containing thrombospondin type 1 domains. Infect Immun 70 (2002) 6987-6995
24. Doyle P.S., Crabb J., and Petersen C. Anti-Cryptosporidium antibodies inhibit infectivity in vitro and in vivo. Infect Immun 61 (1993) 4079-4084
25. Dubremetz J.F., Garcia-Reguet N., Conseil V., and Fourmaus M.N. Apical organelles and host-cell invasion by Apicomplexa. Int J Parasitol 28 (1998) 1007-1013
26. Duby J.P., Speer C.A., and Fayer R. Cryptosporidiosis of man and animals (1990), CRC Press, Boca Raton, FL
27. DuPont H., Chappell C., Sterling C.R., Okhuysen P.C., Pose J.B., and Jakobowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 332 (1995) 855
28. Edge T., Byrne J.M., Johnson R., Robertson W., and Stevenson R. Waterbourne pathogens (2003), Environment Canada, National Water Research Institute
29. El-Suewy K.A., and Eid R.A. Immunolocalization of an enterotoxic glycoprotein exoantigen on the secretory organelles of Cryptosporidium parvum sporozoites. Parasite 11 (2004) 225-230
30. Enriquez F.J., and Riggs M.W. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection. Infect Immun 66 (1998) 4469-4473
31. Fayer R., and Ungar B.L.P. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev 50 (1986) 458
32. Fayer R., Andrews C., Ungar B.L., and Blagburn B. Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. J Parasitol 75 (1989) 393-397
33. Fayer R., Perryman L.E., and Riggs M.W. Hyperimmune bovine colostrum neutralizes Cryptosporidium sporozoites and protects mice against oocyst challenge. J Parasitol 75 (1989) 151-153
34. Fayer R., Guidry A., and Blagburn B.L. Immunotherapeutic efficacy of bovine clostral immunoglobulin from a hyperimmunised cow against cryptosporidiosis in neonatal mice. Infect Immun 58 (1990) 2962
35. Fayer R., Speer C.A., and Dubey J.P. The general biology of Cryptosporidium. In: Fayer R. (Ed). Cryptosporidium and Cryptosporidiosis (1997), CRC Press, Inc., Boca Raton 251
36. Fayer R., Morgan U., and Upton S.J. Epidemology of Cryptosporidium: transmission, detection and identification. Int J Parasitol 30 (2000) 1305-1322
37. Freedman D.J., Tacket C.O., Delehanty A., Maneval D.R., and Crabb J.H. Milk antibodies against purified colonization factor antigens are protective in a human enterotoxigenic Escherichia coli challenge study. 96th general meeting of the American society of microbiology: Abstracts (1996) 371
38. Frevert U., Sinnis P., Cerami C., Shreffler W., Takacs B., and Nussenxweig V. Malaria circumsporozoite protein binds to heparin sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med 177 (1993) 1287-1298
39. Frost F.J., and Craun G.F. Serologic response to human Cryptosporidium infections. Infect Immun 66 (1998) 4008-4009
40. Frost F.J., Muller T., Craun G.L., Calderon D.L., and Hubbs S.A. So many oocysts, so few outbreaks. J Am Waterworks Assoc 89 (1997) 8-9
41. Frost F.J., Calderon R.L., Muller T.B., Curry M., Rodman J.S., Moss D.M., et al. A two-year follow-up survey of antibody to Cryptosporidium in Jackson county, Oregon following an outbreak of waterborne disease. Epidemiol Infect 212 (1998) 213-217
42. Frost F.J., Muller T., Craun G.F., Fraser D., Thompson D., Notenboom R., et al. Serological analysis of a cryptosporidiosis epidemic. Int J Epidemiol 29 (2000) 376-379
43. Frost F.J., Roberts M., Kunde T.R., Craun G., Tollestrup K., Harter L., et al. How clean must our drinking water be: the importance of protective immunity. J Infect Dis 191 (2005) 809-814
44. Greenberg P.D., and Cello J.P. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Human Retrovirol 13 (1996) 348-354
45. Gut J., and Nelson R.G. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK dells in vitro. J Eukaryot Microbiol 41 (1994) 42S-43S
46. Hammer D.H., Ward J., Tzipori S., Pereira M.E.A., Alroy J.P., and Keusch G.T. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infect Immun 62 (1994) 2208-2213
47. He H., Zhao B., Liu L., Zhou K., Qin X., Zhang Q., et al. The humoral and cellular immune responses in mice induced by DNA vaccine expressing the sporozoite surface protein of Cryptosporidium parvum. DNA Cell Biol 23 (2004) 335-339
48. Hijjawi N.S., Meloni B.P., Morgan U.M., and Thompson R.C.A. Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture. Int J Parasitol 31 (2001) 1048-1055
49. Hijjawi N.S., Meloni B.P., Ryan U.M., Olson M.E., and Thompson R.C. Successful in vitro cultivation of Cryptosporidium andersoni: evidence for the existence of novel extracellular stages in the life cycle and implications for the classification of Cryptosporidium. Int J Parasitol 32 (2002) 1719-1726
50. Huang B.Q., Chen X.-M., and LaRusso N.F. Cryptosporidium parvum attachment to and internalization by human biliary epithelia in vitro: a morphologic study. J Parasitol 90 (2004) 212-221
51. Hunter P.R., Hughes S., Woodhouse S., Raj N., Syed Q., Chalmers R.M., et al. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis 39 (2004) 504-510
52. Hunter P.R., Hughes S., Woodhouse S., Syed Q., Verlander N.Q., Chalmers R.M., et al. Sporadic cryptosporidiosis case-control study with genotyping. Emerg Infect Dis 10 (2004) 1241-1249
53. Jenkins M.C., and Fayer R. Cloning and expression of cDNA encoding an antigenic Cryptosporidium parvum protein. Mol Biochem Parasitol 71 (1995) 149-152
54. Jenkins M.C., Fayer R., Tilley M., and Upton S.J. Cloning and expression of a cDNA encoding epitopes shared by 15- and 60-kilodalton proteins of Cryptosporidium parvum sporozoites. Infect Immun 61 (1993) 2377-2382
55. Jenkins M.C., O'Brien C., Trout J., Guidry A., and Fayer R. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice. Vaccine 17 (1999) 2453-2460
56. Jenkins M.C., Trout J., Murphy C., Harp J.A., Higgins J., Wergin W., et al. Cloning and expression of a DNA sequence encoding a 41-kilodalton Cryptosporidium parvum oocyst wall protein. Clin Diagn Lab Immunol 6 (1999) 912-920
57. Joe A., Hamer D.H., Kelley M.A., Pereira M.E., Keusch G.T., Tzipori S., et al. Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. J Eukaryot Microbiol 41 (1994) 44S
58. Joe A., Verdon R., Tzipori S., Keusch G.T., and Ward H.D. Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. Infect Immun 66 (1998) 3429-3432
59. Juranek D.D. Cryptosporidiosis. Sources of infection and guidelines for prevention. Clin Infect Dis 21 (1995) 57-61
60. Juranek D.D., Addiss D.G., Arrowood M.J., Colley D.G., Kaplan J.E., Perciasepe R., et al. Cryptosporidiosis and public health: workshop report. J Am Waterworks Assoc 87 (1995) 69-80
61. Kappe S., Bruderer T., Gantt S., Fujioka H., Nussenzweig V., and Menard R. Conservation of a gliding motility and cell invasion machinery in apicomplexan parasites. J Cell Biol 147 (1999) 937-943
62. Kipriyanov S.M., and Little M. Generation of recombinant antibodies. Mol Biotechnol 12 (1999) 173-201
63. Kjos S.A., Jenkins M., Okhuysen P.C., and Chappell C.L. Evaluation of recombinant oocyst protein CP41 for detection of Cryptosporidium-specific antibodies. Clin Diagn Lab Immunol 12 (2005) 268-272
64. Kuhls T.L., Mosier D.A., Crawford D.L., and Griffis J. Seroprevalence of Cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis 18 (1994) 731-735
65. Lally N.C., Baird G.D., McQuay S.J., Wright F., and Oliver J.J. A 2358-base pair DNA fragment from Cryptosporidium parvum encoding a repetitive oocyst protein. Mol Biochem Parasitol 56 (1992) 69-78
66. Langer R.C., and Riggs M.W. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells. Infect Immun 67 (1999) 5282-5291
67. Langer R.C., Schaefer D.A., and Riggs M.W. Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL. Infect Immun 69 (2001) 1661-1670
68. Leav B.A., Mackay M.R., Anyanwu A., O' Connor R.M., Cevallos A.M., et al. Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa. Infect Immun 70 (2002) 3881-3890
69. Lengerich E.J., Addiss D.G., Marx J.J., Ungar B.L.P., and Juranek D.D. Increased exposure to cryptosporidia among dairy farmers in Wisconsin. J Infect Dis 167 (1993) 1252-1255
70. Levine, N. D., ed. (1985). Phylum II Apicomplexa Levine 1970, pp. 322-374. Allen Press, Lawrence.
71. Lisle J.T., and Rose J.B. Cryptosporidium contamination of water in the USA and UK: a mini review. J Water SRT-Auat 44 (1995) 103-117
72. Little M., Kipriyanov S.M., Le Gall F., and Moldenauer G. Of mice and men: hybridoma and recombinant antibodies. Immunol Today 21 (2000) 364-370
73. Lovett J.L., Howe D.K., and Sibley L.D. Molecular characterization of a thrombospondin-related anonymous protein homologue in Neospora caninum. Mol Biochem Parasitol 107 (2000) 33-43
74. Mallon M., MacLeod A., Wastling J., Smith H., Reilly B., and Tait A. Population structures and the role of genetic exchange in the zoonotic pathogen Cryptosporidium parvum. J Mol Evol 56 (2003) 407-417
75. Mallon M.E., MacLeod A., Wastling J.M., Smith H., and Tait A. Multilocus genotyping of Cryptosporidium parvum Type 2: population genetics and sub-structuring. Infect Genet Evol 3 (2003) 207-218
76. Martin-Gomez S., Alvarez-Sanchez M.A., and Rojo-Vazquez F.A. Immunization protocols against Cryptosporidium parvum in ovines: protection in suckling lambs. Vet Parasitol 129 (2005) 11-20
77. Mead J.R., Arrowood M.J., and Sterling C.R. Antigens of Cryptosporidium sporozoites recognized by immune serum of infected animals and humans. J Parasitol 74 (1988) 135-143
78. Meisel J.L., Perera D.R., Meligro C., and Rubin C.E. Overwhelming watery diarrhea associated with a Cryptosporidium in an immunosuppressed patient. Gastroenterology 70 (1976) 1156
79. Mineo J.R., and Kasper L.H. Attachment of Toxoplasma gondii to host cells involved major surface protein SAG-1 (P30). Exp Parasitol 79 (1994) 11-20
80. Montgomery D.L., Ulmer J.B., Donnelly J.J., and Liu M.A. DNA vaccines. Pharmacol Ther 74 (1997) 195-205
81. Moon H.W., Woodmansee D.B., Harp J.A., Abel S., and Ungar B.L.P. Lacteal immunity to enteric cyrptosporidiosis in mice: immune dams do not protect their suckling pups. Infect Immun 56 (1988) 649-653
82. Morales M.A.G., Mele R., Ludovisi A., Bruschi F., Tosini F., and Pozio E. Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins. Infect Immun 72 (2004) 1306-1310
83. Morgan-Ryan U.M., Fall A., Ward L.A., Hijjawi N., Sulaiman I., Fayer R., et al. Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiiae) from Homo sapiens. J Eukaryot Microbiol 49 (2002) 433-440
84. Morrissette N.S., and Sibley L.D. Cytoskeleton of apicomplexan parasites. Microbiol Mol Biol Rev (2002) 66
85. Moss D.N., Bennett S.N., Arrowood M.J., H. M.R., L. P.H., W. S.P., et al. Kinetic and isotypic analysis of specific immunoglobulins from crew members with cryptosporidiosis on a US Coast Guard cutter. J Eukaryot Microbiol 41 (1994) 52S-55S
86. Moss D.M., McDonald V., Dyson D.A., Catchpole J., Uni S., Iseki M., et al. The antibody response to 27-, 17-, and 150 kDa Cryptosporidium antigens following experimental infections in humans. J Infect Dis 178 (1998) 827-833
87. Nanduri J., Williams S., Aji T., and Flanigan T.P. Characterization of an immunogenic glycocalyx on the surfaces of Cryptosporidium parvum oocysts and sporozoites. Infect Immun 67 (1999) 2022-2024
88. Nesterenko M.V., Woods K., and Upton S.J. Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell. Biochim Biophys Acta 1454 (1999) 165-173
89. Newman R., Zu S., Wuhib T., Lima A., Guerrant R., and Sears S. Household epidemiology of Cryptosporidium parvum infection in an urban community in Northeast Brazil. Ann Intern Med 120 (1994) 500-505
90. Nime F.A., Burek J.D., Page D.L., Holscher M.A., and Yardley J.H. Acute enterocolitis in a human being infected with Cryptosporidium. Gastroenterology 70 (1976) 592
91. Nord J., Ma P., DiJohn D., Tzipori S., and Tacket C.O. Treatment with bovine hyperimmune bovine colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 4 (1990) 28-32
92. O'Donoghue P.J. Cryptosporidium and cryptosporidiosis in man and animals. Int J Parasitol 25 (1995) 139
93. Okhuysen P.C., Chappell C.L., Sterling C.R., Jakubowski W., and DuPont H.L. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun 66 (1998) 441-443
94. Okhuysen P.C., Chappell C.L., Crabb J.H., Sterling C.R., and Dupont H.L. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis 180 (1999) 1275-1281
95. Peng M.M., Xiao L., Freeman A.R., Arrowood M.J., Excalante A.A., Weltman A.C., et al. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis 3 (1997) 567-573
96. Perryman L.E., Riggs M.W., Mason P.H., and Fayer R. Kinetics of Cryptosporidium parvum sporozoite neturalization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum. Infect Immun 58 (1990) 257-259
97. Perryman L.E., Jasmer D.P., Riggs W., Bohnet S.G., McGuire T.C., and Arowood M.J. A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Mol Biochem Parasitol 80 (1996) 137-147
98. Perryman L.E., Kapil S.J., Jones M.L., and Hunt E.L. Protection of calves against cryptosporidiosis with immune bovine colostrums induced by a Cryptosporidium parvum recombinant protein. Vaccine 17 (1999) 2142-2149
99. Petersen C., Gut J., Doyle P.S., Crabb J.H., Nelson R.G., and Leech J.H. Characterization of a > 900,000-Mr Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimune bovine colostral immunoglobulin. Infect Immun 60 (1992) 5132-5138
100. Petersen C., Gut J., Leech J.H., and Nelson R.G. Identification and initial characterization of five Cryptosporidium parvum sporozoite antigen genes. Infect Immun 60 (1992) 2343-2348
101. Pokorny N.J., Weir S.C., Carreno R.A., Trevors J.T., and Lee H. Influence of temperature on Cryptosporidium parvum oocyst infectivity in river water samples as detected by tissue culture assay. J Parasitol 88 (2002) 641-643
102. Potocnjak P., Yoshida N., Nussenzweig S., and Nussenzweig V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (PB44) protect mice against malarial infection. J Exp Med 151 (1980) 1504-1513
103. Priest J.W., Kwon J.P., Moss D.M., Roberts J.M., Arrowood M.J., and Dwokin M.S. Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens. J Clin Microbiol 37 (1999) 1385-1392
104. Priest J.W., Kwon J.P., Arrowood M.J., and Lammie P.J. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Mol Biochem Parasitol 106 (2000) 261-271
105. Priest J.W., Arrowood M.J., and Lammie P.J. The immunodominant 17-kDa antigen from C. parvum is glycosylphosphatidylinositol-anchored. Mol Biochem Parasitol 113 (2001) 117-126
106. Priest J.W., Mehlert A., Arrowood M.J., Riggs M.W., and Ferguson M.A.J. Characterization of a low molecular weight glycolipid antigen from Cryptosporidium parvum. J Biol Chem 278 (2003) 522212-522222
107. Reperant J.M., Naciti M., Chardes T., and Bout D. Immunological characterization of a 17-kDa antigen from Cryptosporidium parvum recognized early by mucosal IgA antibodies. FEMS Microbiol Lett 99 (1992) 7-14
108. Reperant J.-M., Naciti M., Iochmann S., Tilley M., and Bout D.T. Major antigens of Cryptosporidium parvum regocnized by serum antibodies from different infected animal species and man. Vet Parasitol 55 (1994) 1-13
109. Riggs M.W. Immunology: host response and development of passive immunotherapy and vaccines. In: Fayer R. (Ed). Cryptosporidium and Cryptosporidiosis (1997), CRC Press, Boca Raton, FL 129-161
110. Riggs M.W. Recent advances in cryptosporidiosis: the immune response. Microbes Infect 4 (2002) 1067-1080
111. Riggs M.W., and Perryman L.E. Infectivity and neutralization of Cryptosporidium parvum sporozoites. Infect Immun 55 (1987) 2081-2087
112. Riggs M.W., McGuire T.C., Mason P.H., and Perryman L.E. Neutralization-sensitive epitopes are exposed on the surface of infectious Cryptosporidium sporozoites. J Immunol 143 (1989) 1340-1345
113. Riggs M.W., Cama V.A., Leary H.L., and Sterling C.R. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect Immun 62 (1994) 1927-1939
114. Riggs M.W., Stone A.L., Yount P.A., Langer R.C., Arrowood M.J., and Bentley D.L. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J Immunol 158 (1997) 1787-1795
115. Riggs M.W., McNeil M.R., Perryman L.E., Stone A.L., Scherman M.S., and O'Connor R.M. Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a B-mannosylated glycolipid. Infect Immun 67 (1999) 1317-1322
116. Riggs M.W., Schaefer D.A., Kapil S.J., Barley-Maloney L., and Perryman L.E. Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis. Antimicrob Agents Chemother 46 (2002) 275-282
117. Robson K.J., Hall J.R., Jennings M.W., Harris T.J., March K., Newbold C.I., et al. A highly conserved amino acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335 (1988) 79-82
118. Rose J.B. Environmental ecology of Cryptosporidium and public health impacts. Ann Rev Publ Health 81 (1997) 709-713
119. Rose J.B., and Slifko T.R. Giardia, Cryptosporidium, and Cyclospora and their impact on foods: a review. J Food Prot 62 (1999) 1059-1070
120. Rose J.B., Huffman D.E., and Gennaccaro A. Risk and control of waterborne cryptosporidiosis. FEMS Microbiol Rev 26 (2002) 113-123
121. Sagidora S., Iochmann S., Mevelec M.N., Dimier-Poisson I., and Bout D. Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses. Parasite Immunol 21 (1999) 507-516
122. Sagodira A., Buzoni-Gatel D., Iochmann S., Naciri M., and Bout D. Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA. Vaccine 17 (1999) 2346-2355
123. Schaefer D.A., Auerbach-Dixon B.A., and Riggs M.W. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis. Infect Immun 68 (2000) 2608-2616
124. Schofield L., Bushell G.R., Cooper J.A., Saul A.J., Upcroft J., and Kidson C. A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognized by inhibitory monoclonal antibodies. Mol Biochem Parasitol 18 (1986) 183-195
125. Schwartzman J.D. Inhibition of penetration-enhancing factor of Toxoplasma gondii by monoclonal antibodies specific for rhoptries. Infect Immun 51 (1986) 760-764
126. Smith H.V., and Rose J.B. Waterborne cryptosporidiosis. Parasitol Today 6 (1990) 8
127. Smith L.M., Priest J.W., Lammie P.J., and Mead J.R. Human T and B cell immunoreactivity to a recombinant 23-kDa Cryptosporidium parvum antigen. J Parasitol 87 (2001) 704-707
128. Smith H.V., Nicols R.A.B., and Grimason A.M. Cryptosporidium excystation and invasion: getting to the guts of the matter. Trends Parasitol 21 (2005) 133-142
129. Spano R., Purl C., Ranucci L., Putignani L., and Crisanti A. Cloning of the entire COWP gene of Cryptosporidium parvum and ultrastructural localization of the protein during sexual stage development. Parasitology 114 (1997) 427-437
130. Spano F., Putignani L., Naitza S., Puri C., Wright S., and Crisanti A. Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. Mol Biochem Parasitol 92 (1998) 147-162
131. Sterling C.R., and Arrowood M.J. Detection of Cryptosporidium sp. infections using a direct immunofluorescent assay. Pediatr Infect Dis 5 (1986) S139-S142
132. Straub T.M., Daly D.S., Wunshel S., Rochelle P.A., DeLeon R., and Chandler D.P. Genotyping Cryptosporidium parvum with an hsp70 single-nucleotide polymorphism microarray. Appl Environ Microbiol 68 (2002) 1817-1826
133. Strong W., Gut J., and Nelson R.G. Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products. Infect Immun 68 (2000) 4117-4134
134. Sturbaum G.D., Jost B.H., and Sterling C.R. Nucleotide changes within three Cryptosporidium parvum surface protein encoding genes differentiate genotype I from genotype II isolates. Mol Biochem Parasitol 128 (2003) 87-90
135. Sulaiman I.M., Xiao L., Yang C., Escalante L., Moore A., Beard C.B., et al. Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect Dis 4 (1998) 681-685
136. Tacket C.O., Binion S.B., Bostwick E., Losonsky G., Roy M.J., and Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg 47 (1992) 276-283
137. Takashima Y., Xuan X., Kimata I., Isek M., Kodama Y., and Nagane N. Recombinant bovine herpesvirus-1 expressing p23 protein of Cryptosporidium parvum induces neutralizing antibodies in rabbits. J Parasitol 89 (2003) 276-282
138. Templeton T.J., Lancto C.A., Vigdorovich V., Liu C., London N.R., Hadsall K.Z., et al. The Cryptosporidium oocyst wall protein is a member of a multigene family and has a homolog in Toxoplasma. Infect Immun 72 (2004) 980-987
139. Tilley M., and Upton S.J. Electrophoretic characterization of Cryptosporidium parvum (KSU-1 isolate) (Apicomplexa: Cryptosporidiidae). Can J Zool 68 (1990) 1513-1519
140. Tilley M., and Upton S.J. Both CP15 and CP25 are left as trails behind gliding sprorozoites of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol Lett 120 (1994) 275-278
141. Tilley M., Fayer R., Guidry S., Upton S.J., and Blagburn B.O. Antigens of oocysts and sporozoites of Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) recognized by bovine colostral antibodies. Infect Immun 58 (1990) 2966-2971
142. Tilley M., Upton S.J., Fayer R., Barta J.R., Chrisp C.E., Freed P.S., et al. Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum. Infect Immun 59 (1991) 1002-1007
143. Tilley M., Eggleston M.T., and Upton S.J. Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies. FEMS Microbiol Lett 13 (1993) 235-240
144. Tomley F.M., and Soldati D.S. Mix and match modules: structure and function of microneme proteins in apicomplexan parasites. Trends Parasitol 17 (2001) 81-88
145. Tomley F.M., Clarke L.E., Kawazoe U., Dijkema R., and Kok J.J. Sequence of the gene encoding an immunodominant microneme protein of Eimeria tenella. Mol Biochem Parasitol 49 (1991) 277-288
146. Tosini F., Caccio S., Tamburrini A., LaRosa G., and Pozio E. Identification and characterization of three antigenic proteins from Cryptosporidium parvum sporozoites using a DNA library expressing poly-histidine tagged peptides. Int J Parasitol 29 (1999) 1925-1933
147. Tosini F., Agnoli A., Mele R., Angeles M., Morales G., and Pozio E. A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage. Mol Biochem Parasitol 134 (2004) 137-147
148. Tzipori S., and Griffiths J.K. Natural history and biology of Cryptosporidium parvum. Adv Parasitol 40 (1998) 5-36
149. Tzipori A., and Ward H. Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect 4 (2002) 1047
150. Tzipori S., and Widmer G. The biology of Cryptosporidium. In: Petry F. (Ed). Cryptosporidiosis and microsporidiosis vol. 6 (2000), Karger 1-32
151. Tzipori S., Robertson D., and Chapman C. Remission of diarrhea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br Med J 2933 (1986) 1276-1277
152. Tzipori S., Robertson D., Cooper D.A., and White L. Chronic cryptosporidial diarrhoae and hyperimmune cow colostrum. Lancet (1987) 344-345 [ii]
153. Ungar B.L.P., and Nash T.E. Quantification of specific antibody response to Cryptosporidium antigens by laser densitometry. Infect Immun 53 (1986) 124-128
154. Ungar B.L., Gilman R.H., Lanata C.F., and Peres-Schael I. Seroepidemiology of Cryptosporidium infection in two Latin American populations. J Infect Dis 157 (1988) 551-556
155. Ungar B.L.P., Mulligan M., and Nutman T.B. Serologic evidence of Cryptosporidium infection in U.S. volunteers before and during Peace Corps service in Africa. Arch Intern Med 149 (1989) 894-897
156. Unger B.L.P., Ward D.J., Fayer R., and Quinn C.A. Cessation of Cryptosporidium-associated diarrhea in an AIDS patient after treatment with hyperimmune bovine colostrum. Gastroenterology 98 (1990) 486-489
157. Wan K.L., Carruthers V.B., Sibley L.D., and Ajioka J.W. Molecular characterisation of an expressed sequence tag locus of Toxoplasma gondii encoding the micronemal protein MIC2. Mol Biochem Parasitol 84 (1997) 203-214
158. Ward H., and Cevallos A.M. Cryptosporidium: molecular basis of host-parasite interaction. Adv Parasitol 40 (1998) 151-178
159. Weidenmann A., Kruger P., and Botzenhart K. PCR detection of Cryptosporidium parvum in environmental samples-a review of published protocols and current developments. J Ind Microbiol Methods 21 (1998) 150-166
160. Weir C., Vesey G., Slade M., Ferrari B., Veal D.A., and Williams K. An immunoglobulin G1 monoclonal antibody highly specific to the wall of Cryptosporidium oocysts. Clin Diagn Lab Immunol 7 (2000) 745-750
161. Winter G., Gooley A.A., Williams K.L., and Slade M.B. Characterization of a major sporozoite surface glycoprotein of Cryptosporidium parvum. Funct Integr Genomics 1 (2000) 207-217
162. Woods K.M., and Upton S.J. Efficacy of select antivirals against Cryptosporidium parvum in vitro. FEMS Microbiol Lett 168 (1998) 59-63
163. Wu Z., Nagano I., Boonmars T., Nakada T., and Takahashi Y. Intraspecies polymorphism of Cryptosporidium parvum revealed by PCR-restriction fragment length polymorphism (RFLP) and RFLP-single-strand conformational polymorphism analyses. Appl Environ Microbiol 69 (2003) 4720-4726
164. Xiao L., Morgan U.M., Fayer R., Thompson R.C.A., and Lal AA. Cryptosporidium systematics and implications for public health. Parisitol Today 16 (2000) 287-292
165. Xiao L., Fayer R., Ryan U., and Upton S.J. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev 17 (2004) 72-97
166. Yau K.Y.F., Lee H., and Hall J.C. Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies. Biotechnol Adv 21 (2003) 599-637